Notable Upgrades: Cerus Corp. (CERS), BioDelivery Sciences (BDSI), NVIDIA Corp. (NVDA), Potash Corp. (POT), Teekay Tankers Ltd. (TNK)
December 19, 2014
Analysts at Cantor Fitzgerald lifted their price target on shares of Cerus Corporation (CERS) to $8 from $6 in a report released on Friday. The firm reiterated a ‘Buy’ rating on the stock. CERS... Read More
from Wall Street Pit
Stock Market Today, July 7, 2014: The Dow Jones Industrial Average dropped more than 50 points as investors weren't willing to take risky positions ahead of earnings season. Cyclical and small-cap... Read More
from Money Morning
Stock Market Today, Jan. 24: U.S. stocks today are ending this week on a heavy note, as investors continue to absorb a swirl of disappointing earnings reports and worrisome manufacturing data from... Read More
from Money Morning
Chelsea Therapeutics International Ltd. (CHTP) recently announced that it received written guidance... Visit StockBlogHub to view complete post. Read More
BioDelivery Sciences International Inc. (BDSI) recently announced that it has finished enrolling... Visit StockBlogHub to view complete post. Read More
category Endo Pharmaceuticals Holdings Inc , BioDelivery Sciences International Inc , ENDP , and 5 more.
Standard and Poor’s Worst Mistake Yet
August 08, 2011
Cephalon Inc. (CEPH) delivered another strong quarter with second quarter earnings coming in at $2.05 per share, six cents above the Zacks Consensus Estimate and well above the year-ago earnings of... Read More
Cephalon, Inc. (CEPH) started 2010 on a strong note with first quarter earnings beating expectations by a wide margin. The company reported first quarter earnings of $1.76 per share, 20 cents above the... Read More
(CEPH) Cephalon Earnings Estimates Up on Company Guidance
March 16, 2010
Earnings estimates for Cephalon, Inc. (CEPH) have gone up significantly following the issuance of a better-than-expected guidance by the company. Cephalon exited 2009 on a strong note with both... Read More
(CEPH) Cephalon Beats Earnings Expectations and Guides Higher
February 12, 2010
Cephalon, Inc. (CEPH) exited 2009 on a strong note with both fourth quarter and full year earnings exceeding expectations. The company reported fourth quarter earnings of $1.66 per share, 6 cents above... Read More
(CEPH) Cephalon Settles Barr Pharmaceuticals Challenge
November 26, 2009
Earlier this month, Cephalon Inc. (CEPH) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical (TEVA). Barr was looking to... Read More
category Watson Pharmaceuticals Inc/ , Teva Pharmaceutical Industries Limited , Drug Manufacturers / Other , and 7 more.
($CEPH) Cephalon Beats Forecasts – Provides Outlook
October 28, 2009
Cephalon Inc. (CEPH) reported strong third-quarter earnings of $1.62 per share that easily surpassed the Zacks Consensus Estimate of $1.42 per share and the year ago earnings of $1.18. Revenues... Read More
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here